99 related articles for article (PubMed ID: 8119664)
1. Renal catabolism of truncated glucagon-like peptide 1.
Ruiz-Grande C; Alarcón C; Alcántara A; Castilla C; López Novoa JM; Villanueva-Peñacarrillo ML; Valverde I
Horm Metab Res; 1993 Dec; 25(12):612-6. PubMed ID: 8119664
[TBL] [Abstract][Full Text] [Related]
2. Renal catabolism of human glucagon-like peptides 1 and 2.
Ruiz-Grande C; Pintado J; Alarcón C; Castilla C; Valverde I; López-Novoa JM
Can J Physiol Pharmacol; 1990 Dec; 68(12):1568-73. PubMed ID: 2085801
[TBL] [Abstract][Full Text] [Related]
3. Renal catabolism of 125I-glicentin.
López-Novoa JM; Santos JC; Villamediana LM; Garrote FJ; Thim L; Moody AJ; Valverde I
Am J Physiol; 1986 May; 250(5 Pt 1):E545-50. PubMed ID: 3706521
[TBL] [Abstract][Full Text] [Related]
4. Glucagon metabolism in the rat.
Emmanouel DS; Jaspan JB; Rubenstein AH; Huen AH; Fink E; Katz AI
J Clin Invest; 1978 Jul; 62(1):6-13. PubMed ID: 659638
[TBL] [Abstract][Full Text] [Related]
5. Endoproteolysis by isolated membrane peptidases reveal metabolic stability of glucagon-like peptide-1 analogs, exendins-3 and -4.
Thum A; Hupe-Sodmann K; Göke R; Voigt K; Göke B; McGregor GP
Exp Clin Endocrinol Diabetes; 2002 May; 110(3):113-8. PubMed ID: 12012270
[TBL] [Abstract][Full Text] [Related]
6. The roles of renal catabolism and uremia in modifying the clearance of fibrinogen and its degradative fragments D and E.
Iio A; Rutherford WE; Wochner RD; Spilberg I; Sherman LA
J Lab Clin Med; 1976 Jun; 87(6):934-46. PubMed ID: 932524
[TBL] [Abstract][Full Text] [Related]
7. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1.
Cani PD; Neyrinck AM; Maton N; Delzenne NM
Obes Res; 2005 Jun; 13(6):1000-7. PubMed ID: 15976142
[TBL] [Abstract][Full Text] [Related]
8. Circulation and degradation of GIP and GLP-1.
Deacon CF
Horm Metab Res; 2004; 36(11-12):761-5. PubMed ID: 15655705
[TBL] [Abstract][Full Text] [Related]
9. Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo.
Deacon CF; Johnsen AH; Holst JJ
J Clin Endocrinol Metab; 1995 Mar; 80(3):952-7. PubMed ID: 7883856
[TBL] [Abstract][Full Text] [Related]
10. N-terminally modified glucagon-like peptide-1(7-36) amide exhibits resistance to enzymatic degradation while maintaining its antihyperglycaemic activity in vivo.
O'Harte FP; Mooney MH; Lawlor A; Flatt PR
Biochim Biophys Acta; 2000 Mar; 1474(1):13-22. PubMed ID: 10699485
[TBL] [Abstract][Full Text] [Related]
11. Prolactin metabolism in the rat: role of the kidney in degradation of the hormone.
Emmanouel DS; Fang VS; Katz AI
Am J Physiol; 1981 May; 240(5):F437-45. PubMed ID: 7235018
[TBL] [Abstract][Full Text] [Related]
12. Effects of glucagon and glucagon-like peptide-1-(7-36) amide on C cells from rat thyroid and medullary thyroid carcinoma CA-77 cell line.
Crespel A; De Boisvilliers F; Gros L; Kervran A
Endocrinology; 1996 Sep; 137(9):3674-80. PubMed ID: 8756532
[TBL] [Abstract][Full Text] [Related]
13. The handling of immunoreactive vasopressin by the isolated perfused rat kidney.
Rabkin R; Share L; Payne PA; Young J; Crofton J
J Clin Invest; 1979 Jan; 63(1):6-13. PubMed ID: 762248
[TBL] [Abstract][Full Text] [Related]
14. GLP-1 effect upon the GPI/IPG system in adipocytes and hepatocytes from diabetic rats.
Márquez L; González N; Puente J; Valverde L; Villanueva-Peñacarrillo ML
Diabetes Nutr Metab; 2001 Oct; 14(5):239-44. PubMed ID: 11806463
[TBL] [Abstract][Full Text] [Related]
15. Renal tubular processing of small peptide hormones.
Carone FA; Peterson DR; Flouret G
J Lab Clin Med; 1982 Jul; 100(1):1-14. PubMed ID: 7045258
[TBL] [Abstract][Full Text] [Related]
16. Effects of fat digestion on appetite, APD motility, and gut hormones in response to duodenal fat infusion in humans.
Feinle C; O'Donovan D; Doran S; Andrews JM; Wishart J; Chapman I; Horowitz M
Am J Physiol Gastrointest Liver Physiol; 2003 May; 284(5):G798-807. PubMed ID: 12684211
[TBL] [Abstract][Full Text] [Related]
17. Effects of intracerebroventricularly injected glucagon-like peptide-1 on cardiovascular parameters; role of central cholinergic system and vasopressin.
Isbil-Buyukcoskun N; Gulec G
Regul Pept; 2004 Apr; 118(1-2):33-8. PubMed ID: 14759554
[TBL] [Abstract][Full Text] [Related]
18. Serum disappearance and catabolism of homologous immunoglobulin fragments in rats.
Arend WP; Silverblatt FJ
Clin Exp Immunol; 1975 Dec; 22(3):502-13. PubMed ID: 1225487
[TBL] [Abstract][Full Text] [Related]
19. Potentiation by methyl pyruvate of GLP-1 insulinotropic action in normal rats.
Valverde I; Cancelas J; Villanueva-Peñacarrillo ML; Malaisse WJ
Int J Mol Med; 2001 Jun; 7(6):621-3. PubMed ID: 11351275
[TBL] [Abstract][Full Text] [Related]
20. Characterization of high-affinity receptors for truncated glucagon-like peptide-1 in rat gastric glands.
Uttenthal LO; Blázquez E
FEBS Lett; 1990 Mar; 262(1):139-41. PubMed ID: 2156728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
